Fig. 1: Phenotypic distribution of different antibiotics in clinical testing. | Communications Medicine

Fig. 1: Phenotypic distribution of different antibiotics in clinical testing.

From: Genomic insights into antibiotic-resistant non-typhoidal Salmonella isolates from outpatients in Minhang District in Shanghai

Fig. 1

a Overall AMR rate clinical testing. n = 458. b Distribution characteristics of AMR in dominant serovars of different classes. c Distribution characteristics of AMR in dominant serovars of different antibiotics. d Distribution characteristics of fluoroquinolone resistance. e Distribution characteristics of beta-lactam resistance. The abbreviations for different antibiotics are as follows: AMP Ampicillin, AMS Ampicillin/Sulbactam, ATM Aztreonam, CFZ Cefazolin, CTX Cefotaxime, CFX Cefoxitin, CPM Cefepime, CXM Cefuroxime, CZA Cefotaxime/Avibactam, CAZ Ceftazidime, IMP Imipenem, ETP Ertapenem, MEM Meropenem, CIP Ciprofloxacin, NOR Norfloxacin, NAL Nalidixic acid, LEV Levofloxacin, AZI Azithromycin, AMK Amikacin, GEN Gentamicin, STR Streptomycin, TET Tetracycline, CHL Chloramphenicol, SXL Sulfamethoxazole, CT Polymyxin E. The error bar represents the standard deviation. The “*” represents P values. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. No significant differences were not shown. Data are presented as mean values with SD. d-e, S. Enteritidis, n = 179; S. I 4,[5],12:i:-, n = 37; S. Infantis, n = 16; S. London, n = 20; S. Thompson, n = 17; and S. Typhimurium, n = 69. d and e, 2012, n = 22; 2013, n = 91; 2014, n = 61; 2015, n = 61; 2016, n = 84; 2017, n = 15; 2018, n = 21; 2019, n = 43; 2020, n = 42; and 2021, n = 18.

Back to article page